RxDoctor Payments Data

Bruce Luxon, MD

Gastroenterology · Washington, DCNPI 1427153501

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $24,613 of the $37,099 with a category attached, or 66.3%. 6 manufacturers reported payments, led by CSL Behring at 25.7% of the total. Reporting peaked in 2024 at $20,687 and has fallen 85.2% since, to $3,058 in 2025. Among gastroenterology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,099in general payments, 2019–2025

Across 26 payments — averaging $1426.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$10K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$9K
  • Spark Therapeutics, Inc.$7K
  • Sanofi$5K
  • Biomarin Pharmaceutical Inc.$4K
  • Pfizer$2K
$24,868in research payments, 2019–2025

Across 12 payments — averaging $2072.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alnylam Pharmaceuticals Inc.$18K
  • Spark Therapeutics, Inc.$3K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • Shire North American Group Inc$1K

What the payments were for

  • Consulting fees$11,35831%
  • Speaking & faculty fees$24,61366%
  • Travel & lodging$4691%
  • Food & beverage$6602%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,099 in reported general payments places this provider in the 90th percentile of 77 gastroenterology providers in District of Columbia.

See all gastroenterology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$20,707
Medicare patients
82
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →